Stemline Therapeutics Inc (NASDAQ:STML)

19.85
BATS BZX Real-Time Price
As of 11:43am ET
 +0.10 / +0.51%
Today’s Change
7.30
Today|||52-Week Range
20.20
+27.24%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues0.00654.2K1.0M898.2K
 
 
 
 
Depreciation And Amortization153.3K153.8K80.3K14.6K
 
 
 
 
 
 
Operating ExpensesGross Income-153.3K------
 
 
General Expenses29.2M38.1M39.8M69.4M
 
 
 
 
 
Research And Development21.2M29.5M27.9M50.2M
 
 
 
 
 
Total Operating Expenses29.3M38.3M39.9M69.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-29.3M-37.6M-38.9M-68.6M
 
 
 
 
 
Other Expenses338.9K1.6K11.4K-6.3K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-28.8M-37.2M-38.3M-67.8M
 
 
 
 
 
Income Taxes0.000.00-25.3K0.00
 
 
Net Income-28.8M-37.2M-38.3M-67.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS12.9M17.3M17.8M23.1M
 
 
 
 
 
Shares To Calculate EPS Diluted12.9M17.3M17.8M23.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$2.23-$2.15-$2.15-$2.94
 
 
 
 
 
EPS Diluted-$2.23-$2.15-$2.15-$2.94